Trial Profile
Subcutaneous Copaxone as Treatment for Dry Age Related Macular Degeneration
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Dry age-related macular degeneration
- Focus Therapeutic Use
- 28 Feb 2017 New trial record